Last updated on May 2017

A Rollover Study to Provide Continued Treatment With Eltrombopag


Brief description of study

This study will provide continued access to treatment with eltrombopag for subjects who are currently participating in a GlaxoSmithKline (GSK) sponsored investigational study of eltrombopag (parent study) and to collect long term safety data.

Clinical Study Identifier: NCT01957176

Contact Investigators or Research Sites near you

Start Over

Novartis Pharmaceuticals

Novartis Investigative Site
St Petersburg, Russian Federation
  Connect »

Novartis Pharmaceuticals

Novartis Investigative Site
St. Petersburg, Russian Federation
0.91miles
  Connect »

Novartis Pharmaceuticals

Novartis Investigative Site
St'Petersburg, Russian Federation
5.69miles
  Connect »